Zheng Tan
Executive ChairmanMr. Zheng Tan serves as Executive Chairman of Immunotech Biopharm Ltd from August 2019 and also serves as its Director since April 2018. He served as Director at BrainAurora Medical Technology Limited since December 2020 and serves as its Chairman and Executive Director since July 2023 and serves as its Chief Strategy Officer since December 2020. He serves as Chairman at Zhejiang Zhiling Ruidong Medical Technology Co., Ltd since June 2023. He serves as Chairman at Zhejiang BrainAurora Medical Technology Co., Ltd since December 2020. Mr. Tan joined BrainAurora Medical Technology Limited in December 25, 2020. He is mainly responsible for overall strategic planning and business direction of the Group. Mr. Tan is currently pursuing an executive master in business administration from United Business Institutes China. Through working with various pharmaceutical companies, he has accumulated experience in leading commercialisation efforts or marketing and sales within the PRC Pharmaceutical industry. From June 1998 to June 2004, he worked at Shaanxi Buchang Pharmaceutical Co., Ltd., a PRC company listed on the Shanghai Stock Exchange, principally engaged in the development and manufacturing of medical drugs, where his last position was an office supervisor at their Tianjin office. From June 2004 to January 2013, Mr. Tan served as an office supervisor at the Beijing office of Shaanxi Kanghui Pharmaceutical Co., Ltd, principally engaged in the research, development and production of pharmaceuticals products. Between January 2013 and August 2015, he worked at Wuhan Heer Medical Technology Development Co., Ltd., a PRC company engaged in, among other things, the development and manufacture of cancer screening and analysis systems, first as an office supervisor at the Beijing office and subsequently as a deputy general manager, where he was responsible for sales, supervision and management of daily matters. He has been a director of JY Research, the offshore intermediate holding company of PRC subsidiaries; Hamiyang, the holding company of JY Research; and the chairman of AK Ruike, an indirect whollyowned subsidiary of Company, since their respective incorporation. He became the director of Beijing Yongtai, since September 2015.
Positions
- Company NameImmunotech Biopharm LtdStock Code06978PositionExecutive Chairman
- Company NameBrainAurora Medical Technology LimitedStock Code06681PositionChief Strategy Officer & ChairmanColleagues
- ZTZheng TanChief Strategy Officer & Chairman
- LCLongjun CaiChief Executive Officer
- JWJunjie WangCFO & Joint Company Secretary
- ZLZhiyuan LaiVice President of Market & Operation
- YMYing Man ShamJoint Company Secretary
- YPYiu Por LamIndependent Non-executive Director
- LTLei TuIndependent Non-Executive Director
- FDFeng DengNon-Executive Director
- TDTao DuanIndependent Non-executive Director
